Mark S. Diamond, Ph.D. - Publications

Affiliations: 
2010 Biology & Biomedical Sciences (Immunology) Washington University, Saint Louis, St. Louis, MO 
Area:
Immunology, Oncology

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kim IK, Diamond M, Yuan S, Kemp S, Li Q, Lin J, Li J, Norgard R, Thomas S, Merolle M, Katsuda T, Tobias J, Politi K, Vonderheide R, Stanger B. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy. Research Square. PMID 37398248 DOI: 10.21203/rs.3.rs-2960521/v1  0.344
2021 Diamond MS, Lin JH, Vonderheide RH. Site-dependent immune escape of highly antigenic tumors without immunoediting. Cancer Immunology Research. PMID 34145076 DOI: 10.1158/2326-6066.CIR-20-0785  0.379
2020 Morrison AH, Diamond MS, Hay CA, Byrne KT, Vonderheide RH. Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity. Proceedings of the National Academy of Sciences of the United States of America. PMID 32213589 DOI: 10.1073/Pnas.1918971117  0.337
2016 Evans RA, Diamond MS, Rech AJ, Chao T, Richardson MW, Lin JH, Bajor DL, Byrne KT, Stanger BZ, Riley JL, Markosyan N, Winograd R, Vonderheide RH. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. Jci Insight. 1. PMID 27642636 DOI: 10.1172/Jci.Insight.88328  0.372
2016 Schmid ET, Pang IK, Carrera Silva EA, Bosurgi L, Miner JJ, Diamond MS, Iwasaki A, Rothlin CV. AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity. Elife. 5. PMID 27350258 DOI: 10.7554/Elife.12414  0.365
2015 Proenca-Modena JL, Hyde JL, Sesti-Costa R, Lucas T, Pinto AK, Richner JM, Gorman MJ, Lazear HM, Diamond MS. IRF-5-dependent signaling restricts Orthobunyavirus dissemination to the central nervous system. Journal of Virology. PMID 26468541 DOI: 10.1128/Jvi.02276-15  0.334
2015 Lazear HM, Nice TJ, Diamond MS. Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. Immunity. 43: 15-28. PMID 26200010 DOI: 10.1016/J.Immuni.2015.07.001  0.395
2015 Sheehan KC, Lazear HM, Diamond MS, Schreiber RD. Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection. Plos One. 10: e0128636. PMID 26010249 DOI: 10.1371/Journal.Pone.0128636  0.591
2015 Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, Diamond MS, Virgin HW. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science (New York, N.Y.). 347: 269-73. PMID 25431489 DOI: 10.1126/Science.1258100  0.308
2014 Thackray LB, Shrestha B, Richner JM, Miner JJ, Pinto AK, Lazear HM, Gale M, Diamond MS. Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection. Journal of Virology. 88: 11007-21. PMID 25031348 DOI: 10.1128/Jvi.01545-14  0.303
2014 Pinto AK, Ramos HJ, Wu X, Aggarwal S, Shrestha B, Gorman M, Kim KY, Suthar MS, Atkinson JP, Gale M, Diamond MS. Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. Plos Pathogens. 10: e1004086. PMID 24743949 DOI: 10.1371/Journal.Ppat.1004086  0.32
2013 Gmyrek GB, Akilesh HM, Graham DB, Fuchs A, Yang L, Miller MJ, Sandoval GJ, Sheehan KC, Schreiber RD, Diamond MS, Swat W. Loss of DAP12 and FcRγ drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCs. Plos One. 8: e76145. PMID 24155889 DOI: 10.1371/Journal.Pone.0076145  0.502
2013 Bhattacharyya S, Zagórska A, Lew ED, Shrestha B, Rothlin CV, Naughton J, Diamond MS, Lemke G, Young JA. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host & Microbe. 14: 136-47. PMID 23954153 DOI: 10.1016/J.Chom.2013.07.005  0.326
2013 Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M, Früh K, Diamond MS. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. Plos Pathogens. 9: e1003118. PMID 23300459 DOI: 10.1371/Journal.Ppat.1003118  0.348
2012 Thackray LB, Duan E, Lazear HM, Kambal A, Schreiber RD, Diamond MS, Virgin HW. Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. Journal of Virology. 86: 13515-23. PMID 23035219 DOI: 10.1128/Jvi.01824-12  0.597
2012 Cox J, Mota J, Sukupolvi-Petty S, Diamond MS, Rico-Hesse R. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. Journal of Virology. 86: 7637-49. PMID 22573866 DOI: 10.1128/Jvi.00534-12  0.302
2012 Purtha WE, Swiecki M, Colonna M, Diamond MS, Bhattacharya D. Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses. Proceedings of the National Academy of Sciences of the United States of America. 109: E898-904. PMID 22431588 DOI: 10.1073/Pnas.1118155109  0.303
2011 Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KC, Murphy KM, Schreiber RD, Diamond MS. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. Plos Pathogens. 7: e1002407. PMID 22144897 DOI: 10.1371/Journal.Ppat.1002407  0.536
2011 Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. The Journal of Experimental Medicine. 208: 1989-2003. PMID 21930769 DOI: 10.1084/Jem.20101158  0.746
2011 Brien JD, Daffis S, Lazear HM, Cho H, Suthar MS, Gale M, Diamond MS. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection. Plos Pathogens. 7: e1002230. PMID 21909274 DOI: 10.1371/Journal.Ppat.1002230  0.3
2011 Lazear HM, Pinto AK, Vogt MR, Gale M, Diamond MS. Beta interferon controls West Nile virus infection and pathogenesis in mice. Journal of Virology. 85: 7186-94. PMID 21543483 DOI: 10.1128/Jvi.00396-11  0.351
2010 Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M, Diamond MS. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. Journal of Virology. 84: 12125-38. PMID 20881045 DOI: 10.1128/Jvi.01026-10  0.306
2009 Daffis S, Suthar MS, Gale M, Diamond MS. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. Journal of Innate Immunity. 1: 435-45. PMID 20375601 DOI: 10.1159/000226248  0.342
2009 Daffis S, Suthar MS, Szretter KJ, Gale M, Diamond MS. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. Plos Pathogens. 5: e1000607. PMID 19798431 DOI: 10.1371/Journal.Ppat.1000607  0.387
2008 Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, Schreiber RD, Murphy TL, Murphy KM. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science (New York, N.Y.). 322: 1097-100. PMID 19008445 DOI: 10.1126/Science.1164206  0.594
2008 Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M, Diamond MS. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. Journal of Virology. 82: 8465-75. PMID 18562536 DOI: 10.1128/Jvi.00918-08  0.385
2007 Daffis S, Samuel MA, Keller BC, Gale M, Diamond MS. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. Plos Pathogens. 3: e106. PMID 17676997 DOI: 10.1371/Journal.Ppat.0030106  0.364
2006 Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 804-19. PMID 17115899 DOI: 10.1089/Jir.2006.26.804  0.765
2006 Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. Journal of Virology. 80: 9424-34. PMID 16973548 DOI: 10.1128/Jvi.00768-06  0.309
2006 Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proceedings of the National Academy of Sciences of the United States of America. 103: 8459-64. PMID 16714379 DOI: 10.1073/Pnas.0603082103  0.34
2006 Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, Diamond MS. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. Journal of Virology. 80: 5338-48. PMID 16699014 DOI: 10.1128/Jvi.00274-06  0.387
2005 Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. Journal of Virology. 79: 13350-61. PMID 16227257 DOI: 10.1128/Jvi.79.21.13350-13361.2005  0.311
2005 Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Interferon-gamma and cancer immunoediting. Immunologic Research. 32: 231-45. PMID 16106075 DOI: 10.1385/Ir:32:1-3:231  0.672
2005 Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. A critical function for type I interferons in cancer immunoediting. Nature Immunology. 6: 722-9. PMID 15951814 DOI: 10.1038/Ni1213  0.644
2005 Dunn GP, Bruce AT, Sheehan KCF, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. Erratum: Corrigendum: A critical function for type I interferons in cancer immunoediting Nature Immunology. 6: 852-852. DOI: 10.1038/Ni0805-852B  0.602
2000 Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. Journal of Virology. 74: 4957-66. PMID 10799569 DOI: 10.1128/Jvi.74.11.4957-4966.2000  0.319
Show low-probability matches.